AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $223 | -12.5% | 9 | 0.0% | 0.00% | – |
Q2 2023 | $255 | +23.2% | 9 | 0.0% | 0.00% | – |
Q1 2023 | $207 | -18.2% | 9 | 0.0% | 0.00% | – |
Q4 2022 | $253 | – | 9 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 9 | -50.0% | 0.00% | – |
Q1 2021 | $930,000 | – | 18 | +100.0% | 0.00% | – |
Q4 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 9 | -99.0% | 0.00% | -100.0% |
Q4 2019 | $43,000 | +22.9% | 909 | -18.0% | 0.00% | 0.0% |
Q3 2019 | $35,000 | +250.0% | 1,109 | +430.6% | 0.00% | – |
Q2 2019 | $10,000 | +900.0% | 209 | +2222.2% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |